Symbol
| ZBTB16
| contributors: mct/pgu - updated : 13-12-2023
|
HGNC name
| zinc finger and BTB domain containing 16
|
HGNC id
| 12930
|
corresponding disease(s)
|
APLZF
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| fusion
|  
|  
|  
|
with RARA, in acute promyelocytic leukaemia and a translocation t(11;17)(q23;21) | |
Susceptibility
|
to autism spectrum disorder |
Variant & Polymorphism
|
| |
Candidate gene
| represents a promising pleiotropic candidate node for metabolic syndrome |
Marker
| can be useful as a late marker of osteoblastic differentiation. |
|
could be a promising tumor biomarker for Gallbladder cancer (GBC) |
Therapy target
|
System | Type | Disorder | Pubmed |
osteoarticular | bone | ostéoporosis | |
Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis | cancer | digestive | liver | |
potential therapeutic target in Gall bladder cancer |
| |
| Plzf-deficient mice (luxoid, Zbtb16Lu) had severe patterning defects of the limbs and the axial skeleton | |
heterozygous mutant (luxoid.Zbtb16(LU)/J) mice deficient in Zbtb16 have hearing and responses to acoustic trauma similar to their wild type littermates but are unable to generate conditioning-induced protection from acoustic trauma |